Dec 16, 2020, 14:05 by

Clinical Ink, a global clinical trial technology company, today announced five years of providing clients with decentralized and hybrid trial solutions. To demonstrate our continued commitment to industry leadership and the movement toward more patient-centric clinical trials, Clinical Ink has joined the Decentralized Trials & Research Alliance (DTRA), which enables collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research.

Dec 16, 2020, 14:05 by

A new study reveals that VisualDx's artificial intelligence solution identifies skin conditions with 68% accuracy across all skin types.

Dec 16, 2020, 14:05 by

CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, today announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients, the new office builds on CluePoints’ presence in the region, as demand for modern analytical software and services enabling proactive and exhaustive identification of clinical study quality issues continues to grow. The new location, along with a team located in Osaka, will strengthen CluePoints’ growing reputation within Japan and bring it closer to its Asia-Pacific region customers.

Dec 16, 2020, 14:05 by

Pioneering research conducted by a team of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust – home to one of the largest lung cancer practices in the UK – has revealed digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems. At the start of the coronavirus pandemic there was limited evidence about the spread of COVID-19 via chest drains which led to uncertainty within the thoracic community about the best medical device to use. Researchers reviewed three different types of chest drainage systems – single chamber, 3 compartment wet-dry suction, and digital drainage system. Results showed that the 3-compartment wet-dry suction system and the digital drainage system did not generate any identifiable aerosolised particles at any of the air leak or drain output volumes considered. Medela’s Thopaz+, a digital chest drainage, and monitoring system can effectively retain pathogen-sized particles and prevent them from subsequently exiting to the environment via the exhaust. Fully supported by clinical evidence from the National Institute for Health and Care Excellence (NICE), Thopax+ is proven to improve outcomes, ensuring a safe and continuous drainage independent of a wall vacuum to provide safer patient care while minimising the risk of cross-contamination.

Dec 16, 2020, 14:05 by

THREAD, an innovative technology and service provider that enables decentralized clinical research, joins a formidable alliance of 50 life sciences and healthcare organizations to accelerate the broad adoption of patient-focused decentralized clinical trials and research.

Dec 15, 2020, 01:00 by User Not Found

Clinical Research News | Since the United States’ first coronavirus case was confirmed in January 2020, COVID-19 has disrupted healthcare in myriad ways—and oncology clinical trials have not been spared. We can do better, and here’s how.

Dec 11, 2020, 01:00 by User Not Found

Clinical Research News I Dogs detect COVID-19 in sweat, safety evaluation of ventilator sharing, two-thirds lose sense of taste and smell, ethics of human challenge trials, Oxford COVID-19 vaccine trial results, blood vessel damage in children, diabetes and cancer patients at greater risk, transmission from mother to neonate rare, and effects of COVID-19 exposure on healthcare workers. Plus: New oral antiviral could block transmission, metformin may reduce death risk in women, and UC Davis joins Novavax for late-stage COVID-19 vaccine trial.

Dec 10, 2020, 01:00 by User Not Found

Clinical Research News | Several years ago, Seattle Children’s Research Institute realized it would need to “think and act” more like a biotech company to ramp up the development of medicines for pediatric use to treat cancer and other typically orphan-status diseases of childhood. Earlier this year, they launched Seattle Children's Therapeutics to do just that.

Dec 8, 2020, 01:00 by User Not Found

Clinical Research News | Four years ago, most patients with acute myeloid leukemia (AML) over the age of 60 faced the double whammy of a five-year survival rate below 5% as well as no FDA-approved targeted therapy available for their particular disease subtype to improve treatment outcomes. The groundbreaking Beat AML umbrella study, sponsored by The Leukemia & Lymphoma Society's (LLS), has been testing a variety of treatment approaches that are providing glimmers of hope against the devastating disease.

Dec 4, 2020, 06:19 by User Not Found

Clinical Research News I One-third of children are asymptomatic, lung tissue recovers well, adverse outcomes unlikely in COVID-19 positive pregnant women, Type O and Rh negative blood groups at lower risk, immune mechanism that triggers cytokine storm, direct oral anticoagulants show no protection, overdose-related cardiac arrest rates surge, trial underway for nasal spray prophylaxis, protective factors in children, and pregnant women suffer mental health effects. Plus: Wuhan lockdown proves effective, ongoing vaccine trials and advancements, and triple combination therapy trial underway.

Dec 2, 2020, 01:00 by User Not Found

Clinical Research News | In most industries, a feasibility study evaluates whether or not a proposed project is possible to undertake or capable of being completed within a given set of parameters. Feasibility in clinical research is not much different. However, we in the clinical research service sector tend to use the term feasibility to address two very different aspects of our service: developing the project strategy and selecting investigational sites.

Nov 30, 2020, 14:40 by User Not Found

Clinical Research News | The National Institute of Allergy and Infectious Diseases (NIAID) announced four NIH HIV clinical trials networks that will lead clinical research over the next seven years to accelerate progress against the HIV pandemic. The new, streamlined network structure is designed to reduce administrative and oversight costs, allowing more funds to be allocated to clinical trials to advance four key areas of research emphasis: HIV prevention; HIV vaccines; HIV/AIDS adult therapeutics; and HIV/AIDS maternal, adolescent and pediatric therapeutics.

Nov 25, 2020, 16:22 by User Not Found

Clinical Research News | New models of implementing informed consent will be needed for clinical trials where participants are weighing the benefits and risks of genome editing, most immediately individuals with sickle cell disease (SCD) for whom the technique is potentially curative. Lessons learned in this new area of research will be important for a growing number of disease conditions.

Nov 23, 2020, 13:35 by User Not Found

Clinical Research News | During the pandemic, some solutions are coming to the forefront to support and enable greater participant engagement. Virtual visits and remote patient monitoring (RPM) technology, which have seen increasing adoption by healthcare providers to help keep patients and staff safe and adherent during the pandemic, can also help keep clinical trials moving forward.

Nov 20, 2020, 11:38 by User Not Found

Clinical Research News I Arthritis drug improves outcomes in elderly, why COVID-19 spares children, increased risk of tracheal complications, E-cigarette users show poor immune response, effects of in-utero exposure, significant rise in depression, UIC launches trials on blood clot prevention, cytokine storm unlikely, and MRS reveals white matter changes. Plus: XPRIZE announces Pandemic Response Challenge, combination therapy advances, and UT opens post-COVID-19 clinic.

Nov 19, 2020, 14:44 by User Not Found

Clinical Research News | A new survey shows that COVID-19 has slowed enrollment, driven changes to protocols, and even paused clinical research. As a result of these issues, many companies are rushing to adopt decentralized clinical trial methods.

Nov 18, 2020, 01:00 by User Not Found

Clinical Research News | Medidata, TriNetX, and Datavant announced a partnership to enable users of Medidata’s end-to-end clinical research platform to securely link their clinical data with patient consent to de-identified patient data without unblinding the study. The real-world data component from TriNetX’s global network of healthcare organizations, has recently been used to gather data on COVID-19 outcomes.

Nov 16, 2020, 15:39 by

PolyActiva Pty Ltd, a clinical-stage ophthalmology biopharmaceutical company, announced the appointment of highly experienced ophthalmic industry expert, Tracy Valorie, as a new member to the company’s Board of Directors.

Nov 16, 2020, 15:38 by

Together with local healthcare providers, CCT will facilitate clinical trials for the AZD1222 COVID-19 VACCINE, an investigational vaccine for the prevention of COVID-19. CCT is recruiting eligible study participants who are 18 years of age or older, not pregnant, in good general health and have not been previously diagnosed with COVID-19.

Nov 16, 2020, 01:00 by User Not Found

Clinical Research News | In CNS studies, to overcome the pileup of complicated eligibility criteria, extensive data collection, relentless monitoring requirements, and hefty patient burden, sponsors, research sites, and patients need a first-rate technology solution. Standard electronic data capture (EDC) applications into which data, once collected, is transcribed for easy handling are inadequate; the transcription step risks error and necessitates time-consuming validation and edit checks.